Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

871 results

Stibbe advises Akzo Nobel

Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents.

Stibbe advises Ballast Nedam and Royal BAM

Succesfully defended Ballast Nedam and Royal BAM in legal proceedings against the Province of Groningen regarding the "Blauwe Stad" (Blue City).

Stibbe advises Credit Suisse

Stibbe advised Credit Suisse on the imposement of a fine by the European Commission for participating in a cartel involving interest rate products denominated in Swiss francs.

Stibbe advises Mylan

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.

Stibbe advises Zeeland Seaports

Stibbe advises Zeeland Seaports in relation to the demolishing and decommissioning of a large phosphorus plant in Vlissingen. The plant, including its buildings, installations and the ground underneath, is highly contaminated with phosphorus, asbestos and

Stibbe advises Pilkington

Successfully defended Pilkington in proceedings against an ACM decision to impose a fine for alleged participation in a cartel in the double-glass sector.

Stibbe advises Aalberts Industries

Successfully defended Aalberts Industries in a Commission appeal against a General Court judgment that had struck down a EUR 100+ million fine imposed on Aalberts.

Stibbe advises Mars

Representing Mars in legal proceedings before the District Court against Nestlé on allegations of abuse of dominance in the chocolate market.

Stibbe advises AkzoNobel

Assisting AkzoNobel in proceedings before the EU General Court concerning the European Commission's attempt to re-publish an extended non-confidential version of the hydrogen peroxide cartel decision (that includes leniency information).

Stibbe advises Warner Music Group

Stibbe advises Warner Music Group on its acquisition of Spinnin’ Records.

Stibbe represents ExxonMobil

Stibbe acted as defence counsel for ExxonMobil in "follow-on" litigation initiated by 'claims vehicle' CDC. CDC seeks damages for loss allegedly suffered as a result of an antitrust infringement in the European market for paraffin wax.

Stibbe represents VodafoneZiggo

Stibbe represented VodafoneZiggo in a dispute with Fox Sports concerning the length of the contracts and the level of fees Ziggo has to pay Fox for broadcasting the football channels in the Netherlands.

Stibbe represents voestalpine

Stibbe represents voestalpine in antitrust damage litigation following on from the European Commission's finding of an antitrust infringement in the pre-stressing steel sector

Stibbe advises Tribune Media Company

Stibbe advises Tribune Media Company on the Dutch law aspects of the sale of its Gracenote division to Nielsen.

Stibbe advises Tata Communications

Stibbe advises Tata Communications on its investment in Teleena Holding B.V., a mobile virtual network enabler headquartered in the Netherlands.

Stibbe represents Simed in dispute with Slotervaart hospital

Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b

Stibbe advises Makro Cash & Carry Belgium

Stibbe acted as longstanding legal counsel for Makro Cash & Carry Belgium in various legal fields, such as socio-economic legislation, competition and unfair competition law, consumer protection, general commercial, etc.

Stibbe represents Supervisory Board members of FC Twente

Stibbe represented members of the Supervisory Board of the Dutch professional football club FC Twente when the club faced financial difficulties in 2016.

Pagination

  • Previous page
  • Page 40
  • Current page 41
  • Page 42
  • Page 43
  • Next page
Reset filters
Date
Content type
  • Article (510)
  • Event (17)
  • Inside Stibbe (28)
  • Interview (1)
  • Matter (200)
  • Podcast (6)
  • People (109)
Expertise
  • (-) EU and Competition Law (485)
  • (-) Litigation and Arbitration (428)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (431)
  • Capital Markets (247)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (878)
  • Corporate Investigations (31)
  • Criminal Law and Enforcement (145)
  • Employment, Benefits and Pensions (418)
  • Energy, Industry and Climate (316)
  • Environment and Planning (894)
  • ESG & Sustainability (302)
  • Financial Regulation (173)
  • Healthcare and Life Sciences (85)
  • Infrastructure and Mobility (193)
  • Insurance (35)
  • Intellectual Property (120)
  • Investment Funds (142)
  • Mass Litigation (91)
  • Privacy and Data Protection (206)
  • Private Equity (198)
  • Procurement Law (125)
  • Public Law (1201)
  • Real Estate (473)
  • Restructuring and Insolvency (116)
  • Sports (27)
  • Tax (452)
  • Tech (196)
  • Technology, Media and Telecommunications (335)
  • Unfair Competition and Consumer Protection (187)
Jurisdiction
  • BE Law (117)
  • EU Law (317)
  • LU Law (16)
  • NL Law (565)
Language
  • Dutch (121)
  • English (743)
  • French (7)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information